• DOI:10.1007/s10495-018-1440-4
Corpus ID: 3424489

Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies

@article{Razaghi2018NegativeRO,
  title={Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies},
  author={Ali Razaghi and K. Heimann and P. Schaeffer and S. Gibson},
  journal={Apoptosis},
  year={2018},
  volume={23},
  pages={93-112}
}

• Ali Razaghi, K. Heimann, +1 author S. Gibson
• Published 2018
• Medicine
• Apoptosis

Cancer is a primary cause of human fatality and conventional cancer therapies, e.g., chemotherapy, are often associated with adverse side-effects, tumor drug-resistance, and recurrence. Molecularly targeted therapy, composed of small-molecule inhibitors and immunotherapy (e.g., monoclonal antibody and cancer vaccines), is a less harmful alternative being more effective against cancer cells whilst preserving healthy tissues. Drug-resistance, however, caused by negative regulation of cell death… Expand

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed